Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase.

Trial Profile

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Feb 2016

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2016 Primary endpoint has been met. (Rate of non-emergence of bloody stool), as per an article published in the Advances in Therapy.
    • 23 Feb 2016 Results published in the Advances in Therapy
    • 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top